MaineMOM aims to improve care for pregnant and postpartum people with opioid use disorder and their infants by integrating maternal and substance use treatment services.
MaineCare MaineMOM services will:
- Offer a team-based approach to care, including a perinatal provider, substance use counselor, patient navigator, nurse care manager, recovery coach, and perinatal provider.
- Provide pregnant and parenting individuals with a treatment plan for counseling, recovery support, and treatment, including medications.
- Provide coordination and a plan for supportive prenatal, delivery, and postpartum care, including family planning.
- Coordinate referrals for other services a person might need during and after pregnancy like health care, housing, or transportation.
MaineMOM Healthcare Partners
The Office of MaineCare Services is collaborating with 17 healthcare sites to test the delivery of MaineMOM Services beginning July 1, 2021.
Resources for Clinicians Treating Opioid Use Disorder (OUD) in Pregnancy
Treatment Recommendations for Opioid Use Disorder during Pregnancy
- Checklist of Evidence-Based Recommendations for Caring for Pregnant Women with Opioid Use Disorder (Office of MaineCare Services, 2021) (PDF)
- Clinical Guidance for Treating Pregnant and Parenting Individuals with Opioid Use Disorder and their Infants (SAMHSA, 2018)
- FAQ on Substance Use and Pregnancy (ACOG, 2020)
- Online Training for Health Providers: Opioid Use and Pregnancy (CDC, 2020)
Buprenorphine Monotherapy vs. Combination Therapy during Pregnancy
- Use of Buprenorphine Monotherapy vs. Combination Therapy During Pregnancy: Proposed Position of Maine Opioid Response Clinical Advisory Committee (2020) (PDF)
Polysubstance Use During Pregnancy
- Fact Sheet on Polysubstance Use During Pregnancy (CDC, 2020)
- Research Report on Substance Use while Pregnant and Breastfeeding (NIDA, 2020)
- Clinical Recommendations on Marijuana Use During Pregnancy and Lactation (ACOG, 2017)
- Quick Reference Clinical Guide on Marijuana During Pregnancy and Breastfeeding (Colorado DPH, 2017)
- Recommended Treatment of Co-Occurring Stimulant Use Disorder and Opioid Use Disorder: Proposed Position of Maine Opioid Response Clinical Advisory Committee (Maine DHHS, 2020)
Screening for Health-Related Social Needs
- MaineMOM CMS Accountable Health Communities’ (AHC) Health-Related Social Needs (HRSN) Screening Tool (Office of MaineCare Services, 2020)
- Treatment Guidance for Substance Use Disorder and Co-Occurring Disorders: SAMHSA TIP 42 (SAMHSA, 2020)
- Clinical Recommendations on Screening for Perinatal Depression (ACOG, 2018)
- Webinar Addressing Perinatal Mood and Anxiety Disorders (ACOG, 2019)
- FAQ on Postpartum Depression (ACOG, 2019) Tools to Support Postpartum Mental Health (Postpartum Support International)
Breastfeeding & Substance Use Disorders
- Clinical Guidelines for Breastfeeding and Substance Use (ABM, 2015)
- Guide to Support Breastfeeding for People with OUD (NNEPQIN, 2018)
- Clinical Report: Marijuana Use During Pregnancy and Breastfeeding: Implications for Neonatal and Childhood Outcomes (AAP, 2018)
Hepatitis C & Substance Use Disorders
- Clinical Recommendations for Hepatitis C Screening in Adults (CDC, 2020)
- Synthesis on Clinical Recommendations for Hepatitis C Screening in Adults and Pregnancy (ACOG, 2020)
- Clinical Recommendations on Treatment for Hepatitis C in People living with SUD (ASAM, 2017)
- Recommended Perioperative Management of Patients Prescribed Buprenorphine for OUD: Proposed Position of Maine Opioid Response Clinical Advisory Committee (2020)
- Clinical Recommendations for Managing Pain During and After Delivery (MCPAP, 2019)
Stigma Awareness and Substance Use Disorders
- Online Resource on Stigma of Substance Use in Pregnancy (March of Dimes)
- Tool to Improve Provider-Patient Conversations about Substance Use (Maine Quality Counts, 2018)
Postpartum Reproductive Planning and Contraceptive Care
- Clinical Recommendations on Optimal Postpartum Care (ACOG, 2018)
- Increasing Access to Reproductive Health for People with OUD (Power to Decide, 2018)
- Overview of the Eat, Sleep, Console Model of Care (NICHQ)
- Approaches to Coordinated Care for Mothers and Infants affected by OUD (AAP, 2020)
- Clinical Recommendations for Testing, Managing, and Treating Hepatitis C in Children (AASLD & IDSA, 2020)
Patient Education Materials and Resources
Opioid Use Disorder During Pregnancy
- Fact Sheets for Treating OUD during Pregnancy (SAMHSA, 2018)
- Poster on Pregnant or Thinking of Having a Baby and OUD (SAMHSA, 2019)
Other Substance Use During Pregnancy
- Patient Education Webpage on Marijuana Use and Pregnancy (CDC, 2018)
- Patient FAQ on Tobacco, Alcohol and Other Drug Use During Pregnancy (ACOG, 2020)
- Patient Education Webpage Substance Use During Pregnancy (UCSF Health)
- Maine QuitLink to Support Tobacco Cessation
Maine Intimate Partner Violence Resources
- Sexual Assault Crisis & Support Center Maine Coalition Against Sexual Assault
- Maine Coalition to End Domestic Violence
Mental Health Disorders
- Patient Education on Postpartum Depression and Anxiety (ACNM, 2019)
- Patient Education on Perinatal Depression (NIH, 2020)
Substance Exposed Infants
MaineMOM Advisory Meeting Minutes
March 16, 2021
December 15, 2020
- Advisory Group & Clinical Committee Meeting Notes (PDF)
- Advisory Group & Clinical Committee Meeting Presentation (PDF)
September 15, 2020
- Advisory Group & Clinical Committee Meeting Notes (PDF)
- Advisory Group & Clinical Meeting Presentation (PDF)
March 10, 2020
June 16, 2020
Maine was awarded $5.3 million cooperative agreement with from the Centers for Medicare and Medicaid (CMS) to participate in the Maternal Opioid Misuse (MOM) model. See the CMS MOM Press Release or the Maine DHHS MOM Award Press Release for more information about the award.
The MaineMOM initiative aims to:
- Implement a “No wrong door" approach to screening, welcoming, and engaging women in care
- Design a system of treatment and recovery for mothers, using a medication first model of Medication Assisted Treatment (MAT)
- Increase access to evidenced-based care by integrated perinatal and substance use healthcare teams
- Coordinate care for pregnant women and mothers with substance use disorders within local communities and across the state of Maine
- Conduct a public outreach campaign aimed at increasing awareness of supportive services and reducing stigma for pregnant women and mothers
See the MaineMOM FactSheet (PDF) for a summary of the model.
Email the MaineMOM@maine.gov for questions about the initiative, upcoming events, and meetings.
This project is supported by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award with 100 percent funding by CMS/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by CMS/HHS, or the U.S. Government.